FDC Limited: peers
FDC Limited beside the 7 companies most like it by industry, size and country: every figure with its date and source, its rank in the group and its percentile in its sector and country.
Side by side#
Every figure with its fiscal year or date and its source. Switch to each company's rank in the group, or its percentile in its sector or country. How ranks are worked out.
| Measure | FDC Limitedbase FDC.BO · 🇮🇳 IN Percentile in Healthcare Percentile in India | Sun Pharma Advanced Research Company Limited SPARC.BO · 🇮🇳 IN Percentile in Healthcare Percentile in India | Orchid Pharma Limited ORCHPHARMA.NS · 🇮🇳 IN Percentile in Healthcare Percentile in India | Bliss GVS Pharma Limited BLISSGVS.BO · 🇮🇳 IN Percentile in Healthcare Percentile in India | IOL Chemicals and Pharmaceuticals Limited IOLCP.BO · 🇮🇳 IN Percentile in Healthcare Percentile in India | Sanofi India Limited SANOFI.BO · 🇮🇳 IN Percentile in Healthcare Percentile in India | Suven Life Sciences Limited SUVEN.BO · 🇮🇳 IN Percentile in Healthcare Percentile in India | Morepen Laboratories Limited MOREPENLAB.BO · 🇮🇳 IN Percentile in Healthcare Percentile in India | Group median |
|---|---|---|---|---|---|---|---|---|---|
| Size | |||||||||
| Market cap (Better neither way: ranked highest first) | $663 MNov 20, 2026 · Market data5th of 8 | $666 MNov 20, 2026 · Market data4th of 8 | $621 MNov 20, 2026 · Market data6th of 8 | $735 MNov 20, 2026 · Market data3rd of 8 | $583 MNov 20, 2026 · Market data7th of 8 | $797 MNov 20, 2026 · Market data2nd of 8 | $821 MNov 20, 2026 · Market data1st of 8 | $533 MNov 20, 2026 · Market data8th of 8 | $665 M8 ranked |
| Employees (Better neither way: ranked highest first) | —— | —— | —— | —— | —— | 3,426As on 2019 · Profileonly one with it | —— | —— | 3,426— |
| Valuation | |||||||||
| P/E ratio (Better neither way: ranked highest first) | 24.6×price Nov 20, 2026 · Market data2nd of 342nd37th | ———— | ———— | 77.4×price Nov 20, 2026 · Market data1st of 384th84th | ———— | 6.8×price Nov 20, 2026 · Market data3rd of 38th6th | ———— | ———— | 24.6×3 ranked |
| Price to sales (Better neither way: ranked highest first) | 3.5×price Nov 20, 2026 · Market data3rd of 448th51st | 39.2×price Nov 20, 2026 · Market data1st of 489th98th | ———— | 9.8×price Nov 20, 2026 · Market data2nd of 473rd83rd | ———— | 2.2×price Nov 20, 2026 · Market data4th of 436th33rd | ———— | ———— | 6.6×4 ranked |
| Price to book (Better neither way: ranked highest first) | 2.7×price Nov 20, 2026 · Market data3rd of 345th31st | 166.4×price Nov 20, 2026 · Market data1st of 3100th100th | ———— | ———— | ———— | 2.9×price Nov 20, 2026 · Market data2nd of 348th33rd | ———— | ———— | 2.9×3 ranked |
Under each figure: its fiscal year, quarter or date, and its source. ↑ higher is better, ↓ lower is better, · better neither way (ranked highest first). Ranks count only the companies with the figure; percentiles place each company among all the companies of its own sector and country with the figure (ten or more needed).
Key: SEC = SEC annual reports (10-K, 20-F, 40-F); ESEF = ESEF annual reports (European and UK listed companies); Editors = The company's annual report, entered by value.today editors; Wikidata = Wikidata, citing the annual report; Scorecard = value.today scorecard: thirty checks on the company's statements, worked out daily; 13F = SEC Form 13F holdings reports; SEC = Dividends declared per share in SEC 10-Q and 10-K filings; Profile = The company's latest reported headcount; Market data = FDC Limited: National Stock Exchange of India, daily market-cap file; Sun Pharma Advanced Research Company Limited: National Stock Exchange of India, daily market-cap file; Orchid Pharma Limited: National Stock Exchange of India, daily market-cap file; Bliss GVS Pharma Limited: National Stock Exchange of India, daily market-cap file; IOL Chemicals and Pharmaceuticals Limited: National Stock Exchange of India, daily market-cap file; Sanofi India Limited: National Stock Exchange of India, daily market-cap file; Suven Life Sciences Limited: National Stock Exchange of India, daily market-cap file; Morepen Laboratories Limited: National Stock Exchange of India, daily market-cap file.
The dot is the company; the line runs from the 10th to the 90th percentile of all the companies of its sector (or country) with the figure, the box holds the middle half and the tick is the median. Each company's newest fiscal year; figures that divide by the market value only with a market cap at most 60 days old. How percentiles are worked out.
| Company | P/E ratio | In its sector | In its country |
|---|---|---|---|
| FDC Limited | 24.6× | 42nd percentile in Healthcaremedian 30.0×, 254 companies | 37th percentile in Indiamedian 32.4×, 549 companies |
| Sun Pharma Advanced Research Company Limited | — | — | — |
| Orchid Pharma Limited | — | — | — |
| Bliss GVS Pharma Limited | 77.4× | 84th percentile in Healthcaremedian 30.0×, 254 companies | 84th percentile in Indiamedian 32.4×, 549 companies |
| IOL Chemicals and Pharmaceuticals Limited | — | — | — |
| Sanofi India Limited | 6.8× | 8th percentile in Healthcaremedian 30.0×, 254 companies | 6th percentile in Indiamedian 32.4×, 549 companies |
| Suven Life Sciences Limited | — | — | — |
| Morepen Laboratories Limited | — | — | — |
Revenue by fiscal year, and the rank in the group#
Revenue of the fiscal year. US dollars at each year's exchange rate; fiscal years as each company names them. Ranks: 1st is the highest (better neither way).
Revenue
Fewer than two years of revenue are on file for these companies.
Rank in the group
Ranks need two fiscal years with the figure for at least two of these companies.
Suggested peers of FDC Limited#
Companies of the same industry, within a hundred times its size (market cap), scored out of 100 for industry, size, country and figures on file. How peers are suggested.
- Sun Pharma Advanced Research Company LimitedSPARC.BO · 🇮🇳 IndiaSame industry: Pharmaceutical · Similar size: $666 M market cap against $663 M · Same country: IndiaMarket cap $666 M (Nov 20, 2026) · revenue $17 M (year to March 2022)95 of 100 (industry or sector 50 + size 30 + country 15)In the group
- Orchid Pharma LimitedORCHPHARMA.NS · 🇮🇳 IndiaSame industry: Pharmaceutical · Similar size: $621 M market cap against $663 M · Same country: IndiaMarket cap $621 M (Nov 20, 2026)95 of 100 (industry or sector 50 + size 30 + country 15)In the group
- Bliss GVS Pharma LimitedBLISSGVS.BO · 🇮🇳 IndiaSame industry: Pharmaceutical · Similar size: $735 M market cap against $663 M · Same country: IndiaMarket cap $735 M (Nov 20, 2026) · revenue $75 M (year to March 2021)94 of 100 (industry or sector 50 + size 29 + country 15)In the group
- IOL Chemicals and Pharmaceuticals LimitedIOLCP.BO · 🇮🇳 IndiaSame industry: Pharmaceutical · Similar size: $583 M market cap against $663 M · Same country: IndiaMarket cap $583 M (Nov 20, 2026)94 of 100 (industry or sector 50 + size 29 + country 15)In the group
- Sanofi India LimitedSANOFI.BO · 🇮🇳 IndiaSame industry: Pharmaceutical · Similar size: $797 M market cap against $663 M · Same country: IndiaMarket cap $797 M (Nov 20, 2026) · revenue $366 M (year to December 2021)94 of 100 (industry or sector 50 + size 29 + country 15)In the group
- Suven Life Sciences LimitedSUVEN.BO · 🇮🇳 IndiaSame industry: Pharmaceutical · Similar size: $821 M market cap against $663 M · Same country: IndiaMarket cap $821 M (Nov 20, 2026)94 of 100 (industry or sector 50 + size 29 + country 15)In the group
- Morepen Laboratories LimitedMOREPENLAB.BO · 🇮🇳 IndiaSame industry: Pharmaceutical · Similar size: $533 M market cap against $663 M · Same country: IndiaMarket cap $533 M (Nov 20, 2026)94 of 100 (industry or sector 50 + size 29 + country 15)In the group
- Gujarat Themis BiosynGUJTHEM.BO · 🇮🇳 IndiaSame industry: Pharmaceutical · Similar size: $495 M market cap against $663 M · Same country: IndiaMarket cap $495 M (Nov 20, 2026)93 of 100 (industry or sector 50 + size 28 + country 15)+ Add
- SMS Pharmaceuticals LimitedSMSPHARMA.BO · 🇮🇳 IndiaSame industry: Pharmaceutical · Similar size: $478 M market cap against $663 M · Same country: IndiaMarket cap $478 M (Nov 20, 2026)93 of 100 (industry or sector 50 + size 28 + country 15)+ Add
- Aarti Drugs LimitedAARTIDRUGS.BO · 🇮🇳 IndiaSame industry: Pharmaceutical · Similar size: $477 M market cap against $663 M · Same country: IndiaMarket cap $477 M (Nov 20, 2026) · revenue $311 M (year to March 2022)93 of 100 (industry or sector 50 + size 28 + country 15)+ Add
- Strides Pharma Science LimitedSTAR.NS · 🇮🇳 IndiaSame industry: Pharmaceutical · Similar size: $962 M market cap against $663 M · Same country: IndiaMarket cap $962 M (Nov 20, 2026) · revenue $378 M (year to March 2022)93 of 100 (industry or sector 50 + size 28 + country 15)+ Add
- Kwality Pharmaceuticals LimitedKPL.BO · 🇮🇳 IndiaSame industry: Pharmaceutical · Similar size: $462 M market cap against $663 M · Same country: IndiaMarket cap $462 M (Nov 20, 2026)93 of 100 (industry or sector 50 + size 28 + country 15)+ Add
Any figure over the years, other peers or a saved group: open this group in the peer workspace.